News
1h
Zacks Investment Research on MSNLLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III StudyShares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.
17h
Lose It! on MSNCoping With Common Side Effects of GLP-1 MedicationsIf you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...
A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results